Výsledky vyhledávání - Rodolfo Passalacqua
- Zobrazuji výsledky 1 - 16 z 16
-
1
-
2
-
3
-
4
-
5
-
6
Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis Autor Michele Ghidini, Gianluca Tomasello, Andrea Botticelli, Sandro Barni, Giampietro Zabbialini, Silvia Seghezzi, Rodolfo Passalacqua, Chiara Braconi, Fausto Petrelli
Vydáno 2017Revisão -
7
Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis Autor Sara Pusceddu, Michele Ghidini, Martina Torchio, Francesca Corti, Gianluca Tomasello, Monica Niger, Natalie Prinzi, Federico Nichetti, Andrea Coinu, Maria Di Bartolomeo, Mary Cabiddu, Rodolfo Passalacqua, Filippo de Braud, Fausto Petrelli
Vydáno 2019Revisão -
8
Regard Phase 3, Randomized Trial of Ramucirumab in Patients with Metastatic Gastric or Gej Adenocarcinoma Following Progression on First-Line Chemotherapy Autor Josep Tabernero, Jiří Tomášek, Dumitru Filip, Rodolfo Passalacqua, Chanchal Goswami, Howard Safran, Lucas dos Santos, Giuseppe Aprile, David Ferry, Y. Choi, Bohuslav Melichar, Mustapha Tehfé, Eldar Topuzov, John Zalcberg, Ian Chau, Jonathan Schwartz, Minori Koshiji, Yanzhi Hsu, Charles S. Fuchs
Vydáno 2013Artigo -
9
Randomised Phase Ii Study Evaluating, As First-Line Chemotherapy, Weekly Oral Vinorelbine As a Single-Agent Versus Weekly Paclitaxel As a Single-Agent in Estrogen Receptor Positive... Autor Matti Aapro, Elżbieta Starosławska, Serafín Morales, Manuel Ruíz Borrego, Saverio Cinieri, E. Szombara, Laura García‐Estévez, N. Tubiana-Mathieu, Christelle Lévy, Marek Z. Wojtukiewicz, Rodolfo Passalacqua, A Ardizzoia, Roberto Hegg, Luis Fein, H. Simon, Eduardo Richardet, Joëlle Egreteau, Ornella Garrone, M. Morand, G. Villanova
Vydáno 2014Artigo -
10
Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data Autor Charles S. Fuchs, Kei Muro, Jiří Tomášek, Eric Van Cutsem, Y. Choi, Sang-Cheul Oh, Howard Safran, G. Bodoky, Ian Chau, Yasuhiro Shimada, Salah‐Eddin Al‐Batran, Rodolfo Passalacqua, Atsushi Ohtsu, Michael Emig, David Ferry, Kumari Chandrawansa, Yanzhi Hsu, Andreas Sashegyi, Astra M. Liepa, H. Wilke
Vydáno 2017Artigo -
11
Trastuzumab-Associated Cardiac Adverse Effects in the Herceptin Adjuvant Trial Autor Thomas Suter, Marion Procter, Dirk J. van Veldhuisen, M Muscholl, Jonas Bergh, Chiara Carlomagno, Timothy Perren, Rodolfo Passalacqua, Claudia Bighin, Jan G.M. Klijn, Ф. Т. Агеев, Erika Hitre, Juergen Groetz, Hiroji Iwata, Małgorzata Knap, Michael Gnant, Susanne Muehlbauer, Alison Spence, Richard D. Gelber, Martine Piccart
Vydáno 2007Artigo -
12
Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial Autor Ana Oaknin, Claire F. Friedman, Lynda D. Roman, Anishka D'souza, Irene Braña, François‐Clément Bidard, Jonathan W. Goldman, Edwin Alvarez, Valentina Boni, Adam C. ElNaggar, Rodolfo Passalacqua, Khanh T.M., Alessandro D. Santin, Kiana Keyvanjah, Feng Xu, Lisa D. Eli, Alshad S. Lalani, Richard Bryce, David M. Hyman, Funda Meric‐Bernstam, David B. Solit, Bradley J. Monk
Vydáno 2020Artigo -
13
Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial Autor Miranda Gogishvili, Tamar Melkadze, Tamta Makharadze, Davit Giorgadze, Mikhail Dvorkin, Konstantin Penkov, К. К. Лактионов, Gia Nemsadze, Marina Nechaeva, Irina Rozhkova, Ewa Kalinka‐Warzocha, Christian Geßner, Brizio Moreno‐Jaime, Rodolfo Passalacqua, Siyu Li, Kristina McGuire, M. Kaul, Anne Paccaly, Ruben G.W. Quek, Bo Gao, Frank Seebach, David M. Weinreich, George D. Yancopoulos, Israel Lowy, Giuseppe Gullo, Petra Rietschel
Vydáno 2022Artigo -
14
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer Autor Fátima Cardoso, Laura J. vanʼt Veer, Jan Bogaerts, Leen Slaets, Giuseppe Viale, Suzette Delaloge, Jean‐Yves Pierga, Étienne Brain, Sylvain Causeret, Mauro Delorenzi, Annuska M. Glas, Vassilis Golfinopoulos, Theodora Goulioti, Susan Knox, Erika Matos, Bart Meulemans, Peter A. Neijenhuis, Ulrike Nitz, Rodolfo Passalacqua, Peter M. Ravdin, Isabel T. Rubio, Mahasti Saghatchian, Tineke J. Smilde, Christos Sotiriou, Lisette Stork, Carolyn Straehle, Geraldine Thomas, Alastair M. Thompson, Jacobus M. van der Hoeven, Peter Vuylsteke, René Bernards, Konstantinos Tryfonidis, Emiel J. Rutgers, Martine Piccart
Vydáno 2016Artigo -
15
Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial) Autor Suresh S. Ramalingam, Jeffrey Crawford, Alex Y. Chang, C. Manegold, Román Pérez-Soler, Jean-Yves Douillard, Nicholas Thatcher, Fabrice Barlési, Taofeek K. Owonikoko, Y. Wang, Philippe Pultar, Jing Zhu, Rajesh Malik, Giuseppe Giaccone, Stephen Della‐Fiorentina, Stephen Begbie, Ross Jennens, Joshua Dass, K. Pittman, N.M. Ivanova, Tatyana Koynova, Petar Petrov, Antoaneta Tomova, Valentina Tzekova, Félix Couture, Vera Hirsh, Ronald L. Burkes, Randeep Sangha, Miloslav Ambruš, Terezie Janaskova, J Musil, J. Novotny, Petr Zatloukal, Jitka Jakesova, Kamil Klenha, Jaromı́r Roubec, J Vaňásek, Jérôme Fayette, Fabrice Barlési, Jaafar Bennouna-Louridi, C. Chouaïd, Julien Mazières, H. Vallerand, G. Robinet, P.-J. Souquet, D. Spaëth, Roland Schött, H. Léna, Y. Martinet, Claude El Kouri, Nathalie Baize, Arnaud Scherpereel, O. Molinier, F. Fuchs, K. Josten, C. Manegold, Norbert Marschner, Folker Schneller, Tobias R. Overbeck, Michael Thomas, Joachim von Pawel, Martin Reck, Wolfgang Schuette, Volker Hagen, Claus-Peter Schneider, V. Georgoulias, Ioannis Varthalitis, Kostas Zarogoulidis, K. Syrigos, Christos N. Papandreou, Csaba Böcskei, Eszter Csánky, Erzsébet Juhász, György Losonczy, Z. Mark, István Molnár, Zsolt Pápai-Székely, S. Tehenes, Ilona Vinkler, Sachin Almel, Ashish Bakshi, Shailesh Bondarde, A Maru, Ashutosh Pathak, R.M. Pedapenki, Krishna Prasad, S.V.S.S. Prasad, Nalini Kilara, D. Gorijavolu, Chetan Deshmukh, S.K.P. John, Lalit Mohan Sharma, D. Amoroso, Emilio Bajetta, Paolo Bidoli, Andrea Bonetti, Filippo de Marinis, Massimo Di Maïo, Rodolfo Passalacqua, Stefano Cascinu
Vydáno 2013Artigo -
16
Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer Autor Nicholas J. Vogelzang, Tomasz M. Beer, Winald R. Gerritsen, Stéphane Oudard, Paweł Wiechno, Bożena Kukiełka-Budny, Vladimír Šámal, Jaroslav Hájek, Susan Feyerabend, Vincent Khoo, Arnulf Stenzl, Tibor Csőszi, Zoran Filipovic, Frederico Gonçalves, А А Прохоров, Eric Cheung, Arif Hussain, Nuno Sousa, Amit Bahl, Syed A. Hussain, Harald Fricke, Pavla Kadlecová, Tomáš Scheiner, Roman Korolkiewicz, Jiřina Bartůňková, Radek Špíšek, Walter M. Stadler, Arthur Berg, Karl‐Heinz Kurth, Celestia S. Higano, Matti Aapro, Michael Krainer, Stephan Hruby, Johannes Meran, S. Polyakov, Jean‐Pascal Machiels, Thierry Roumeguère, Koen Ackaert, Nicolaas Lumen, Thierry Gil, Velko Minchev, Antoaneta Tomova, Borislav D. Dimitrov, Marchela Koleva, Antonio Juretić, Ana Fröbe, Željko Vojnović, Martin Drabek, L. Jarolím, Tomáš Büchler, Eva Kindlová, Jan Schraml, Milada Zemanová, Prausova Jana, Bohuslav Melichar, Martina Chodacká, Jan Jansa, Gedske Daugaard, Nicolas Delonchamps, Brigitte Duclos, Stéphane Culine, G. Deplanque, Sylvestre Le Moulec, Peter Hammerer, Gerald Rodemer, Manuel Ritter, Axel S. Merseburger, Marc‐Oliver Grimm, Ilija Damjanoski, Manfred Wirth, Martin Burmester, Kurt Miller, Jan Herden, Bastian Keck, Christian Wuelfing, Alexander Winter, Martin Boegemann, Ingo Kausch von Schmeling, Paolo Fornara, E. Jaeger, G. Bodoky, Zsuzsanna Pápai, Géza Böszörményi-Nagy, Paola Vanella, Héctor Soto Parrà, Rodolfo Passalacqua, Francesco Ferraù, Michele Maio, Lucia Fratino, Enrico Cortesi, Gunta Purkalne, Jolita Asadauskienė, Rasa Jančiauskienė, Skaistė Tulytė, Alvydas Česas, Marco B. Polée, Brigitte C. M. Haberkorn, Fons van de Eertwegh, Pieter van den Berg, Aart Beeker
Vydáno 2022Artigo
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Oncology
Cancer
Chemotherapy
Breast cancer
Confidence interval
Hazard ratio
Gastroenterology
Surgery
Clinical endpoint
Meta-analysis
Randomized controlled trial
Alternative medicine
Chemoradiotherapy
Cochrane Library
Colorectal cancer
Gemcitabine
Pathology
Placebo
Adjuvant chemotherapy
Adverse effect
Bevacizumab
Biliary tract cancer
Biology
Clinical trial
Disease
Gene
Immunotherapy
Irinotecan